MetLife Bull Case
Here are some ways that investors could benefit from investing in MetLife, Inc.:
- MetLife, Inc. recently hit a new 52-week high of $101.44, with the current stock price trading at $100.27, reflecting strong momentum and market confidence in the company's recent performance and strategic direction.
- Analyst sentiment has turned increasingly positive, with JPMorgan Chase & Co. raising its price target to $110.00 and DOWLING & PARTN lifting its FY2026 earnings estimate to $10.30 per share, which is significantly above the consensus estimate of $9.88, suggesting potential for higher-than-expected profitability.
- The company demonstrated strong earnings power in its most recent quarterly report, beating consensus estimates by $0.13 per share with an EPS of $2.43, while maintaining a robust return on equity of 23.39%, indicating efficient use of shareholder capital.
- MetLife, Inc. has approved a $3.00 billion stock repurchase plan, which allows the company to buy back up to 4.8% of its shares, a move that often signals management believes the stock is undervalued and can support share price growth by reducing the number of outstanding shares.
- With a dividend yield of 2.37% and a beta of 0.78, the stock offers a relatively stable income stream with lower volatility compared to the broader market, making it an attractive option for income-focused investors seeking defensive exposure.